The trend is your friend. Given what we already know about Elite, they've proven critics wrong time-and-time again. As the previous CCs indicated, Hakim has the motivation, passion to succeed, and overall ability and experience to take the company to the next level in terms of the Nasdaq without a reverse split and just by adding growth to its drug pipeline to generate revenues. Cheers!